Full text is available at the source.
Abstract
Endogenous GLP-1R and GLP-2R signaling is essential for protecting the intestine from T cell-mediated enteropathy.
- Gut injury from T cell activation is increased in mice lacking GLP-1R or GLP-2R.
- Mice with selective loss of intestinal proglucagon gene expression also show increased intestinal damage.
- Administration of the GLP-2R agonist teduglutide reduces intestinal damage in specific mouse models.
- The GLP-1R agonist semaglutide also alleviates T cell-induced intestinal injury when administered alone or with teduglutide.
- These findings suggest distinct protective roles for GLP-1R and GLP-2R in immune-mediated intestinal injury.
Simplified